本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Chinook Therapeutics, Inc.

40.39
0.0000
成交量:- -
成交額:- -
市值:29.00億
市盈率:-11.49
高:40.39
開:40.39
低:40.39
收:40.39
52周最高:40.39
52周最低:40.39
股本:7,180.50萬
流通股本:6,038.70萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-3.5165
每股收益(LYR):-2.9185
淨資產收益率:-56.85%
總資產收益率:-26.82%
市淨率:8.12
市盈率(LYR):-13.84

資料載入中...

2023/06/13

重要事件披露

Form 8-K - Current report
2023/06/12

重要事件披露

Form 8-K - Current report
2023/05/09

重要事件披露

8-K - Current report
2023/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/24

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/04/13

重要事件披露

8-K - Current report
2023/03/13

重要事件披露

8-K - Current report
2023/03/10

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/27

重要事件披露

8-K - Current report
2023/02/27

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/24

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/10

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/11/10

重要事件披露

8-K - Current report
2022/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/22

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership